18 May 2020
Introduction
Artificial intelligence (AI) is considered a significant factor for emerging researches in the healthcare sector, particularly in the pharma and biopharma industry wherein computing technologies are used to analyze the data. There is no mutually agreed definition of AI; however, processes adopting human intelligence for activities such as reasoning, adoption for learning, understanding and interacting are usually considered key factors for defining AI. The healthcare industry is rapidly growing, with a focus on scientific innovations and transforming rationally.
While the innovations related to the field of target drug delivery, drug discovery, preclinical and clinical development are increasing with the technical development, AI has the potential to further strengthen the healthcare system. India, being the fastest growing economy with the second largest population, has a significant stake in the AI revolution.
Read the article here.
Article was 1st published in The Life Sciences Lawyer (CTC Media)
For further information, please contact:
Rajeev Kumar, Partner, LexOrbis
rajeev@lexorbis.com
